Evidence map›Paper›PMID 30663218›Full record

ArticleInternational journal of laboratory hematology2019

The first report of hemoglobin E in combination with the highly unstable alpha-globin variant Hb Adana: The importance of molecular confirmation.

Ahlem Achour, Elke de Grouw, Femke van Erp, Sandra Arkesteijn, Rianne Schaap, Jeanet Ter Huurne, Sharda Bisoen, Maaike Verschuren, Cornelis L Harteveld

Abstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of laboratory hematology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ahlem AchourDepartment of Clinical genetics/LDGA, Leiden University Medical Centre, Leiden, The Netherlands.ORCID 0000-0001-5262-434X
Elke de GrouwDepartment of Clinical Chemistry, RadboudUMC, Nijmegen, The Netherlands.
Femke van ErpDepartment of Clinical Genetics, RadboudUMC, Nijmegen, The Netherlands.
Sandra ArkesteijnDepartment of Clinical genetics/LDGA, Leiden University Medical Centre, Leiden, The Netherlands.
Rianne SchaapDepartment of Clinical genetics/LDGA, Leiden University Medical Centre, Leiden, The Netherlands.
Jeanet Ter HuurneDepartment of Clinical genetics/LDGA, Leiden University Medical Centre, Leiden, The Netherlands.
Sharda BisoenDepartment of Clinical genetics/LDGA, Leiden University Medical Centre, Leiden, The Netherlands.
Maaike VerschurenDepartment of Clinical genetics/LDGA, Leiden University Medical Centre, Leiden, The Netherlands.
Cornelis L HarteveldDepartment of Clinical genetics/LDGA, Leiden University Medical Centre, Leiden, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alpha-Globinsalpha-ThalassemiaDNA Mutational AnalysisHemoglobin EHemoglobins, AbnormalHumansMaleMiddle Agedalpha-Globinshemoglobin AdanaHemoglobin EHemoglobins, Abnormal

Identifiers

PMID30663218
PMCPMC6936223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.